351 related articles for article (PubMed ID: 26097049)
1. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
2. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
3. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy.
Liu J; Dai Y; Zhou F; Long Z; Li Y; Liu B; Xie D; Tang J; Tan J; Yao K; Zhang Y; Tang Y; He L
Urol Oncol; 2016 Nov; 34(11):484.e1-484.e8. PubMed ID: 27341738
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Soave A; John LM; Dahlem R; Minner S; Engel O; Schmidt S; Kluth LA; Fisch M; Rink M
Urology; 2015 Jul; 86(1):92-8. PubMed ID: 26051839
[TBL] [Abstract][Full Text] [Related]
7. Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.
Bruins HM; Arends TJ; Pelkman M; Hulsbergen-van de Kaa CA; van der Heijden AG; Witjes JA
Clin Genitourin Cancer; 2014 Jun; 12(3):190-5. PubMed ID: 24332508
[TBL] [Abstract][Full Text] [Related]
8. Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy.
Oh JJ; Kang MY; Jo JK; Lee HM; Byun SS; Lee SE; Lee S; Hong SK
Int J Urol; 2015 Dec; 22(12):1112-7. PubMed ID: 26290403
[TBL] [Abstract][Full Text] [Related]
9. Restrictive transfusion in radical cystectomy is safe.
Syan-Bhanvadia S; Drangsholt S; Shah S; Cai J; Miranda G; Djaladat H; Daneshmand S
Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526
[TBL] [Abstract][Full Text] [Related]
10. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
11. Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.
Fairey AS; Kassouf W; Aprikian AG; Chin JL; Izawa JI; Fradet Y; Lacombe L; Rendon RA; Bell D; Cagiannos I; Drachenberg DE; Lattouf JB; Estey EP
Urol Oncol; 2012; 30(6):825-32. PubMed ID: 21889368
[TBL] [Abstract][Full Text] [Related]
12. Effects of thiazolidinedione in patients with active bladder cancer.
Li R; Metcalfe MJ; Ferguson JE; Mokkapati S; Nogueras González GM; Dinney CP; Navai N; McConkey DJ; Sahai SK; Kamat AM
BJU Int; 2018 Feb; 121(2):244-251. PubMed ID: 28872778
[TBL] [Abstract][Full Text] [Related]
13. Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy.
Hu B; Satkunasivam R; Schuckman A; Miranda G; Cai J; Daneshmand S
World J Urol; 2015 Oct; 33(10):1397-402. PubMed ID: 25549760
[TBL] [Abstract][Full Text] [Related]
14. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.
Mason RJ; Frank I; Bhindi B; Tollefson MK; Thompson RH; Karnes RJ; Tarrell R; Thapa P; Boorjian SA
World J Urol; 2017 Dec; 35(12):1879-1884. PubMed ID: 28913657
[TBL] [Abstract][Full Text] [Related]
15. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
16. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
Fairey AS; Daneshmand S; Wang L; Schuckman A; Lieskovsky G; Djaladat H; Cai J; Miranda G; Skinner EC
Urol Oncol; 2014 Feb; 32(2):110-6. PubMed ID: 23499168
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
[TBL] [Abstract][Full Text] [Related]
18. Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada.
Wissing MD; O'Flaherty A; Dragomir A; Tanguay S; Kassouf W; Aprikian AG
BMC Urol; 2023 Jul; 23(1):119. PubMed ID: 37452329
[TBL] [Abstract][Full Text] [Related]
19. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
Ge P; Wang ZC; Yu X; Lin J; He Q
BMC Urol; 2015 May; 15():46. PubMed ID: 26025446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
